A carregar...
Utilizing Synergistic Potential of Mitochondria-Targeting Drugs for Leukemia Therapy
Acute myeloid leukemia (AML) is an aggressive group of cancers with high mortality rates and significant relapse risks. Current treatments are insufficient, and new therapies are needed. Recent discoveries suggest that AML may be particularly sensitive to chemotherapeutics that target mitochondria....
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7146088/ https://ncbi.nlm.nih.gov/pubmed/32318340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00435 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|